The resident, identified in inspection records as R2, told federal inspectors on September 19 that he was supposed to receive Latanoprost eye drops for his glaucoma but didn't get them during his first ten days at the facility. When he asked nursing staff about the missing medication, they told him it was "on order."
"His Glaucoma could be getting worse if he does not take his eye drops as his Ophthalmologist prescribes," the resident explained to inspectors, according to the September 23 complaint inspection report.
His doctor had ordered Latanoprost 0.005% eye drops to be administered in each eye at bedtime starting August 15. The medication reduces blood pressure in the eyes, a critical treatment for glaucoma patients who risk permanent vision damage without proper pressure control.
Pharmacy records show the facility's first fill of the medication wasn't until August 26 — eleven days after the doctor's order. A second fill occurred September 12.
The facility's medication administration records document that staff failed to give the resident his eye drops on August 15, 16, 18, and continuously from August 20 through August 25. Each missed dose was marked as "medication not available."
During the inspection, the Director of Nurses confirmed the resident "did not have his Latanoprost Ophthalmic eye drops 0.005% for the first ten days of his admission." She acknowledged that Latanoprost eye drops "are given to help reduce the blood pressure in R2's eyes for Glaucoma."
The resident's care plan, updated August 15, specifically instructed staff to "Administer medication per orders." His physician's order sheet from September 2025 documented the continuing prescription for the eye drops to treat "eye deficiencies."
Federal inspectors reviewed medication administration for eight residents and found repeated failures to provide prescribed medications to one of the five residents in their sample. The violation represents a medication error rate that federal regulators consider unacceptable for nursing home operations.
The facility's own policy, revised in August 2023, states that "residents shall receive their medications on a timely basis in accordance with state and federal guidelines, and within established facility policies."
Glaucoma affects more than 3 million Americans and is a leading cause of blindness. The condition causes gradual damage to the optic nerve, typically through elevated pressure within the eye. Without consistent treatment, patients can experience irreversible vision loss.
Latanoprost belongs to a class of medications called prostaglandin analogs that work by increasing the outflow of fluid from the eye, thereby reducing intraocular pressure. Missing doses can allow pressure to build up again, potentially accelerating optic nerve damage.
The resident's experience highlights a fundamental breakdown in the facility's medication management system. Despite having a cognitively intact patient who could advocate for himself and ask questions about his missing medication, staff failed to ensure timely procurement and administration of a sight-preserving drug.
The inspection occurred following a complaint about the facility's operations. Federal inspectors determined the medication failures caused "minimal harm or potential for actual harm" to residents, though the long-term consequences of untreated glaucoma can be severe and permanent.
For ten days, while facility staff told the resident his medication was "on order," his eye pressure remained uncontrolled by the treatment his ophthalmologist had prescribed. The resident understood the stakes, telling inspectors his glaucoma could worsen without the drops, but remained dependent on a system that had failed to prioritize his prescribed care.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Accolade Healthcare of Savoy from 2025-09-23 including all violations, facility responses, and corrective action plans.